Join
Live feed
·
PRReleasevia Quantisnow
Cellectar Biosciences Inc. logo

Cellectar Biosciences to Participate at Oppenheimer 3rd Annual Targeted Radiopharmaceutical Therapies in Oncology Summit

ByQuantisnow·Wall Street's wire, on your screen.
CLRB· Cellectar Biosciences Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CLRB (Cellectar Biosciences Inc.) and more on Quantisnow.